HomayoonKhanlouMD
Infectious Disease • Beverly Hills, CAHIV/AIDS Medicine, Healthcare Associated Infections, STD Medicine
Director, Medical Institute of Immunology and Infectious Diseases
Dr. Khanlou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
242 S Robertson Blvd
Beverly Hills, CA 90211Phone+1 323-397-0897
Education & Training
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1996 - 1999
Paris Descartes University Faculty of Medical ScienceClass of 1995
Certifications & Licensure
CA State Medical License 1998 - 2026
PA State Medical License 1997 - 2002- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System Start of enrollment: 2010 Aug 01
Publications & Presentations
PubMed
- 183 citationsPhase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cellsRonald T. Mitsuyasu, Thomas C. Merigan, Andrew Carr, Jerome A. Zack, Mark A. Winters
Nature Medicine. 2009-03-01 - 38 citationsImmunomodulation of Antiretroviral Drug-Suppressed Chronic HIV-1 Infection in an Oral Probiotic Double-Blind Placebo-Controlled TrialOtto O. Yang, Theodoros Kelesidis, Robert Cordova, Homayoon Khanlou
AIDS Research and Human Retroviruses. 2014-09-30 - 45 citationsMaraviroc: a new CCR5 antagonist.Shilpa Sayana, Homayoon Khanlou
Expert Review of Anti-Infective Therapy. 2009-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
